<DOC>
	<DOCNO>NCT00608075</DOCNO>
	<brief_summary>The purpose research study brain structure , function chemistry patient bipolar disorder receive lithium , FDA-approved treatment bipolar mania , order well understand benefit treatment respond medication . Studying may help improve treatment outcome patient bipolar disorder .</brief_summary>
	<brief_title>Neurofunctional Neurochemical Markers Treatment Response Bipolar Disorder</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Bipolar Disorder</mesh_term>
	<mesh_term>Lithium Carbonate</mesh_term>
	<criteria>Inclusion Criteria bipolar patient ( Manic= , depressed=60 ; 30 patients/year ) : 1 . The patient meet DSMIV criterion type I bipolar disorder , manic mixed , depress . 2 . The patient index Young Mania Rating Scale ( YMRS ) total score &gt; 15 Montgomery Asberg Rating Scale ( MADRS ) total score &gt; 20 . 3 . The patient 15 55 year old . Inclusion Criteria Healthy subject ( N=40 ) : 1 . Healthy subject age 15 55 year . 2 . Healthy subject history Axis I psychiatric disorder . 3 . Healthy subject firstdegree relative affective psychotic disorder . Exclusion criterion : All subject exclude participation follow reason . 1 . Any medical neurological disorder could influence fMRI MRS result . 2 . A history mental retardation estimate IQ total score &lt; 85 . 3 . An MRI scan contraindicate subject reason , include psychological impediment inside MR scanner . 4 . The patient attend followup visit .</criteria>
	<gender>All</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>